Sumatriptan Tablet, Film Coated
Product Images NDC 68788-8535

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 68788-8535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Sumatriptan Figure 1)

Chemical Structure (Sumatriptan Figure 1)
Chemical structure of Sumatriptan, showing the molecular arrangement including sulfonamide, indole, and aminoethyl groups along with a succinate moiety as depicted.*
FDA Label Image

Figure 1 (Sumatriptan Figure 2)

Figure 1 (Sumatriptan Figure 2)
A line chart displaying estimated probability of response over time in minutes from initial dose for placebo and various dosages (25 mg, 50 mg, 100 mg) of Sumatriptan tablets. The x-axis represents time up to 240 minutes, and the y-axis shows the probability from 0% to 100%. Higher dosages correspond to higher probabilities of response.*
FDA Label Image

Figure 2 (Sumatriptan Figure 3)

Figure 2 (Sumatriptan Figure 3)
A line graph showing the estimated probability of remediation or rescue over time in hours from the initial dose for Sumatriptan doses of 25 mg, 50 mg, 100 mg, and placebo. The y-axis represents probability from 0% to 100%, and the x-axis depicts time up to 24 hours. Different symbols indicate each dose response, illustrating the effectiveness progression over time.*
FDA Label Image

Sumatriptan Succinate Tablets 100mg (Sumatriptan Figure 6)

Sumatriptan Succinate Tablets 100mg (Sumatriptan Figure 6)
Label for Sumatriptan Succinate Tablets 100 mg film-coated tablets by Preferred Pharmaceuticals Inc., marked as generic for Imitrex. The label includes directions in English and Spanish for dosage, warnings about tablet handling and storage, and mentions manufacturer as Bionpharma Inc. Additional fields for lot, batch, expiration date, and NDC are present but not filled.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.